The CFAR at Emory is funded by nine institutes of the National Institutes of Health (P30 AI050409) -- NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIGMS, and NIDDK -- to help expand the breadth and depth of NIH-funded research in HIV/AIDS. Additional funding is provided by the Georgia Research Alliance, the Atlanta Clinical and Translational Science Institute, Children's Healthcare of Atlanta, and multiple units of Emory University including the offices of the President and the University Provost, the Woodruff Health Science Center, the Emory University School of Medicine, the Rollins School of Public Health, the Nell Hodgson Woodruff School of Nursing, the Woodruff Cancer Institute, and the Yerkes National Primate Research Center.
CFAR members conduct research at Children's Healthcare of Atlanta, the Veteran's Affairs Medical Center, Morehouse School of Medicine, and in multiple units of Emory University including Emory College, the Emory University School of Medicine, the Rollins School of Public Health, the Nell Hodgson Woodruff School of Nursing, the Winship Cancer Institute, the Emory Vaccine Center, and the Yerkes National Primate Research Center.
Adjunct CFAR investigators conduct research at the Morehouse School of Medicine and other academic institutions throughout the Southeast.
Although the CFAR provides support for all HIV/AIDS research taking place at Emory University, we prioritize four major domains of HIV/AIDS research: 1) Immunology and Vaccine Development, 2) HIV Pathogenesis and Drug Discovery, 3) Clinical and Translational Science, and 4) Prevention Science, with cross-cutting support for International Research.
The CFAR was initiated with institutional funds in 1997 and first funded by NIH in 1998. At that time, there was already excellent research being done in various, albeit rather isolated, units at Emory and a strong commitment to care for HIV-infected patients at clinical facilities staffed by Emory faculty. The challenge facing the newly funded CFAR was to increase the breadth, depth, and visibility of HIV/AIDS research on campus by creating a community of science through enhancing communications among scientists across disciplines and sites, identifying opportunities for scientific collaboration, and greatly expanding research capacity through focused recruitments and the provision of CFAR Core facilities.
In large part due to the CFAR, HIV/AIDS research at Emory has grown rapidly in the intervening years and the CFAR is now recognized as a flagship research program on campus.
The CFAR provides research facilities, institutional infrastructure and leadership, support for the recruitment and development of faculty, communications and sharing of scientific findings, and the promotion of interactions between CFAR members and with outside institutions and the community through an Administrative Core, a Developmental Core, and five Science Cores: Biostatistics & Biomedical Informatics, Clinical Research, Immunology, Prevention Science, and Virology & Molecular Biomarkers.
CFAR Cores provide: 1) expert consultations, 2) developmental and requested research services, 3) access to shared equipment and research space, 4) provision of biological, chemical, labware, and documentary materials, 5) training, and 6) seed grant funding.
The CFAR also supports the work of three interdisciplinary Scientific Working Groups: Non-human Primate Models for HIV Pathogenesis and Vaccines, HIV Reservoirs and Eradication, and Neuro-AIDS.
Scientific oversight for the CFAR is provided by the CFAR Leadership and an External Scientific Advisory Committee. Community input is provided by a Community Advisory Committee. Strategic planning is done in conjunction with members of the CFAR Science Council and the CFAR Executive Council.